Cargando…

Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma

Detalles Bibliográficos
Autores principales:	Hu, Xiaoyi, Bao, Mingyang, Huang, Jiacheng, Zhou, Lin, Zheng, Shusen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716885/ https://www.ncbi.nlm.nih.gov/pubmed/33330112 http://dx.doi.org/10.3389/fonc.2020.617539

Ejemplares similares

Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Hu, Xiaoyi, et al.
Publicado: (2020)

The Landscape of Immune Cells Indicates Prognosis and Applicability of Checkpoint Therapy in Hepatocellular Carcinoma
por: Huang, Jiacheng, et al.
Publicado: (2021)

Metabolomic biomarkers for the diagnosis and post-transplant outcomes of AFP negative hepatocellular carcinoma
por: Lin, Zuyuan, et al.
Publicado: (2023)

Corrigendum: CDT1 is a Novel Prognostic and Predictive Biomarkers for Hepatocellular Carcinoma
por: Cai, Chenhui, et al.
Publicado: (2021)

Development and Validation of Epigenetic Modification-Related Signals for the Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Lu, Maoqing, et al.
Publicado: (2021)

Development of Models to Predict Postoperative Complications for Hepatitis B Virus-Related Hepatocellular Carcinoma
por: Bao, Mingyang, et al.
Publicado: (2021)

Corrigendum: Serum Biomarker Panel for Diagnosis and Prognosis of Pancreatic Ductal Adenocarcinomas
por: Mehta, Shreya, et al.
Publicado: (2021)

Identification of CFHR4 associated with poor prognosis of hepatocellular carcinoma
por: Ding, Qinglin, et al.
Publicado: (2022)

Identification METTL18 as a Potential Prognosis Biomarker and Associated With Immune Infiltrates in Hepatocellular Carcinoma
por: Li, Tian-Hao, et al.
Publicado: (2021)

Corrigendum: Upregulated LINC01667 Expression Is Correlated With Poor Prognosis in Hepatocellular Carcinoma
por: Zhang, Kainan, et al.
Publicado: (2021)

Identification and Validation of TYMS as a Potential Biomarker for Risk of Metastasis Development in Hepatocellular Carcinoma
por: Li, Shuai, et al.
Publicado: (2021)

Preoperative Prediction Power of Imaging Methods for Microvascular Invasion in Hepatocellular Carcinoma: A Systemic Review and Meta-Analysis
por: Huang, Jiacheng, et al.
Publicado: (2020)

Corrigendum: Identification of Mitochondrial-Related Prognostic Biomarkers Associated With Primary Bile Acid Biosynthesis and Tumor Microenvironment of Hepatocellular Carcinoma
por: Zhang, Tao, et al.
Publicado: (2022)

Identification and Validation of Ubiquitin-Specific Proteases as a Novel Prognostic Signature for Hepatocellular Carcinoma
por: Ni, Wenkai, et al.
Publicado: (2021)

Identification of PLOD Family Genes as Novel Prognostic Biomarkers for Hepatocellular Carcinoma
por: Yang, Bo, et al.
Publicado: (2020)

Identification of LSM Family Members as Novel Unfavorable Biomarkers in Hepatocellular Carcinoma
por: Zhuang, Hongkai, et al.
Publicado: (2022)

SKA1/2/3 is a biomarker of poor prognosis in human hepatocellular carcinoma
por: Song, Guo-Qiang, et al.
Publicado: (2022)

New Blood Biomarkers for the Diagnosis of AFP-Negative Hepatocellular Carcinoma
por: Wang, Ting, et al.
Publicado: (2020)

Peripheral Blood Genetic Biomarkers for the Early Diagnosis of Hepatocellular Carcinoma
por: Song, Ting, et al.
Publicado: (2021)

Corrigendum: High expression of nectin-1 indicates a poor prognosis and promotes metastasis in hepatocellular carcinoma
por: Wang, Xuequan, et al.
Publicado: (2023)

ZCCHC17 Served as a Predictive Biomarker for Prognosis and Immunotherapy in Hepatocellular Carcinoma
por: Liu, Fahui, et al.
Publicado: (2022)

The Progress in the Treatment of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
por: Luo, Fangzhou, et al.
Publicado: (2021)

Identification and Validation of Tumor Stromal Immunotype in Patients With Hepatocellular Carcinoma
por: Li, Wei, et al.
Publicado: (2019)

Identifying and Validating Potential Biomarkers of Early Stage Lung Adenocarcinoma Diagnosis and Prognosis
por: Chen, Yingji, et al.
Publicado: (2021)

Identification and validation of a potential key gene SGOL1 for poor prognosis in hepatocellular carcinoma based on a bioinformatics approach
por: Fei, Xiaobin, et al.
Publicado: (2022)

RNF135 Promoter Methylation Is Associated With Immune Infiltration and Prognosis in Hepatocellular Carcinoma
por: Wang, Xiao, et al.
Publicado: (2022)

Establishment and validation of nomogram model for the diagnosis of AFP-negative hepatocellular carcinoma
por: Liu, Long, et al.
Publicado: (2023)

Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma
por: Li, Wang, et al.
Publicado: (2020)

Identification of Key Genes in Purine Metabolism as Prognostic Biomarker for Hepatocellular Carcinoma
por: Su, Wen-Jing, et al.
Publicado: (2021)

Corrigendum: OIT3 serves as a novel biomarker of hepatocellular carcinoma by mediating ferroptosis via regulating the arachidonic acid metabolism
por: Wen, Jie, et al.
Publicado: (2022)

Exosome Cargos as Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Zeng, Yulai, et al.
Publicado: (2023)

Editorial: Identification of novel biomarkers for pancreatic and hepatocellular cancers
por: Matteucci, Laura, et al.
Publicado: (2022)

Corrigendum: SPOCK1 promotes the development of hepatocellular carcinoma
por: Váncza, Lóránd, et al.
Publicado: (2023)

CDT1 Is a Novel Prognostic and Predictive Biomarkers for Hepatocellular Carcinoma
por: Cai, Chenhui, et al.
Publicado: (2021)

Corrigendum: ASPM is a prognostic biomarker and correlates with immune infiltration in kidney renal clear cell carcinoma and liver hepatocellular carcinoma
por: Deng, Tingting, et al.
Publicado: (2022)

Discovery of a haptoglobin glycopeptides biomarker panel for early diagnosis of hepatocellular carcinoma
por: Kohansal-Nodehi, Mahdokht, et al.
Publicado: (2023)

Systematic Construction and Validation of an RNA-Binding Protein-Associated Model for Prognosis Prediction in Hepatocellular Carcinoma
por: Tian, Siyuan, et al.
Publicado: (2021)

Identification of a Novel Four-Gene Signature Correlated With the Prognosis of Patients With Hepatocellular Carcinoma: A Comprehensive Analysis
por: Zhu, Weihua, et al.
Publicado: (2021)

A Novel Multimodal Radiomics Model for Predicting Prognosis of Resected Hepatocellular Carcinoma
por: He, Ying, et al.
Publicado: (2022)

Development and validation of a pyradiomics signature to predict initial treatment response and prognosis during transarterial chemoembolization in hepatocellular carcinoma
por: Peng, Jie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1hn7qjclsob15orhaa4jee4uub